|
Mar 21
|
Phio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies
|
|
Mar 13
|
Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity Research
|
|
Mar 6
|
Phio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin Disorders
|
|
Dec 7
|
Phio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross Proceeds
|